← All trials
NCT00986063
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2009
- Primary completion
- Jul 1, 2012
- Completion date
- Dec 1, 2012
- First posted
- —
- Last posted
- —
- Enrollment
- 1200
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Mahidol UniversityLead sponsor
- Mahidol UniversityOverall official - principal investigator
- Mahidol UniversitySponsor investigator
- Mahidol UniversityCollaborator
- Chulalongkorn UniversityCollaborator
- Thammasat UniversityCollaborator
- Srinakharinwirot UniversityCollaborator
- RIKENCollaborator
- National Institutes of Health (NIH)Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.